1.
Infect Control Hosp Epidemiol
; 42(4): 499-501, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-2096341
2.
J Microbiol Immunol Infect
; 54(1): 27-36, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-813694
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical presentations and may result in severe respiratory failure. The global SARS-CoV-2-associated viral pneumonia pandemic was first reported in December 2019 in China. Based on known pharmacological mechanisms, many therapeutic drugs have been repurposed to target SARS-CoV-2. Among these drugs, remdesivir appears to be the currently most promising according to several clinical trials and reports of compassionate use. In this mini-review, we summarize the current evidence on the efficacy and challenges of remdesivir for the treatment of coronavirus disease 2019 (COVID-19).
Subject(s)
Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Antiviral Agents/administration & dosage , COVID-19 Drug Treatment , Adenosine Monophosphate/administration & dosage , Alanine/administration & dosage , COVID-19/epidemiology , China/epidemiology , Clinical Trials as Topic , Humans , Pandemics , Randomized Controlled Trials as Topic , SARS-CoV-2/drug effects
3.
Laryngoscope
; 130(11): E694, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-652675
4.
Lung Cancer
; 146: 376-377, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-601984
Subject(s)
Antineoplastic Agents/therapeutic use , Coronavirus Infections/drug therapy , Lung Neoplasms/drug therapy , Pandemics , Pneumonia, Viral/drug therapy , B7-H1 Antigen/antagonists & inhibitors , Betacoronavirus , COVID-19 , CTLA-4 Antigen/antagonists & inhibitors , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Genes, cdc/drug effects , Humans , Immunotherapy , Lung Neoplasms/complications , Lung Neoplasms/epidemiology , Lung Neoplasms/virology , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , Programmed Cell Death 1 Receptor/antagonists & inhibitors , SARS-CoV-2
5.
J Thorac Oncol
; 15(8): e129-e131, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-591110
Subject(s)
Coronavirus Infections/diagnosis , Lung Diseases, Interstitial/chemically induced , Lung Diseases, Interstitial/diagnosis , Pneumonia, Viral/diagnosis , Protein Kinase Inhibitors/adverse effects , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus/isolation & purification , Coronavirus Infections/virology , Diagnosis, Differential , ErbB Receptors/antagonists & inhibitors , Humans , Lung Diseases, Interstitial/pathology , Lung Diseases, Interstitial/virology , Lung Neoplasms/drug therapy , Lung Neoplasms/enzymology , Pandemics , Pneumonia, Viral/virology , Protein Kinase Inhibitors/therapeutic use , SARS-CoV-2
6.
Kaohsiung J Med Sci
; 36(7): 572-573, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-381828
Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumococcal Infections/epidemiology , Pneumococcal Infections/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Betacoronavirus , COVID-19 , Disinfection , Hand Disinfection , Humans , Masks , Patient Isolation , Personal Protective Equipment , SARS-CoV-2 , Taiwan/epidemiology
7.
J Microbiol Immunol Infect
; 54(1): 129-130, 2021 Feb.
Article
in English
| MEDLINE | ID: covidwho-88426
8.
J Microbiol Immunol Infect
; 53(3): 381-383, 2020 Jun.
Article
in English
| MEDLINE | ID: covidwho-59910
Subject(s)
Coronavirus Infections/prevention & control , Hospitals, Community , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/transmission , Health Personnel , Health Policy , Humans , Information Dissemination , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , Public Health , Quarantine , SARS-CoV-2 , Taiwan/epidemiology
9.
J Microbiol Immunol Infect
; 53(3): 394-395, 2020 Jun.
Article
in English
| MEDLINE | ID: covidwho-47497